Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q36424315)
Watch
English
Development of therapeutic agents for older patients with acute myelogenous leukemia.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
4699173
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20496262%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 February 2020
review article
1 reference
stated in
Europe PubMed Central
title
Development of therapeutic agents for older patients with acute myelogenous leukemia
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
4699173
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20496262%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 February 2020
author name string
Christopher S Hourigan
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
4699173
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20496262%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 February 2020
Judith E Karp
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
4699173
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20496262%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 February 2020
publication date
1 June 2010
1 reference
stated in
Europe PubMed Central
PMC publication ID
4699173
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20496262%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 February 2020
published in
Current Opinion in Investigational Drugs
1 reference
stated in
Europe PubMed Central
PMC publication ID
4699173
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20496262%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 February 2020
volume
11
1 reference
stated in
Europe PubMed Central
PMC publication ID
4699173
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20496262%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 February 2020
issue
6
1 reference
stated in
Europe PubMed Central
PMC publication ID
4699173
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20496262%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 February 2020
page(s)
669-677
1 reference
stated in
Europe PubMed Central
PMC publication ID
4699173
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20496262%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 February 2020
cites work
Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
How I treat acute promyelocytic leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
Anthracycline dose intensification in acute myeloid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
High-dose daunorubicin in older patients with acute myeloid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
A 2-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acute myeloid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
Blood and marrow transplantation in elderly acute myeloid leukaemia patients - older certainly is not better
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
Age and acute myeloid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
Combination therapy with DNA methyltransferase inhibitors in hematologic malignancies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
Preclinical and clinical development of cyclin-dependent kinase modulators
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
30 September 2017
Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
28 June 2018
Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
28 June 2018
Phase I and II study of fludarabine phosphate in leukemia: therapeutic efficacy with delayed central nervous system toxicity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
28 June 2018
Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
21 September 2018
A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
21 September 2018
Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
21 September 2018
Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
21 September 2018
Timed sequential therapy of acute leukemia with flavopiridol: in vitro model for a phase I clinical trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
21 September 2018
Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699173
retrieved
4 December 2018
Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/20496262
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/20496262
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/20496262
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/20496262
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/20496262
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
The outcomes and costs of acute myeloid leukemia among the elderly
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/20496262
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
PMC publication ID
4699173
1 reference
stated in
Europe PubMed Central
PMC publication ID
4699173
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20496262%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 February 2020
PubMed publication ID
20496262
1 reference
stated in
Europe PubMed Central
PMC publication ID
4699173
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20496262%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit